Results 381-400 of 846 for hpv

Joint Oireachtas Committee on Health: Royal College of Obstetricians and Gynaecologists Independent Expert Panel Review into Cervical Screening: Discussion (18 Dec 2019) See 8 other results from this debate

...screen. Repeated screening, and compliance with or adherence to repeated screening, is an important way of trying to raise the overall sensitivity of cervical screening. It is quite clear that HPV testing will reset the risk, because there will be an increased detection of underlying pre-cancerous lesions, and that will happen. It is also the case that because women who are HPV negative...

Written Answers — Department of Health: Vaccination Programme (18 Sep 2013)

James Reilly: Information provided to me by the Health Service Executive report that the 2011-2012 National Human Papilloma Virus (HPV) Vaccine Campaign, which provides protection against the main viruses associated with cervical cancer, has been well received. HSE figures show that almost 86% (25,224 students from a cohort of 29,500) of first year girls in second level schools have received their three...

Written Answers — Department of Health: Vaccination Programme (15 Nov 2017) See 1 other result from this answer

Simon Harris: ...best practice. All relevant and appropriate information is taken into account when deciding to make changes to the State's immunisation programmes. NIAC has made a recommendation that the HPV vaccine should be given to boys. My Department asked the Health Information and Quality Authority (HIQA) to carry out a health technology assessment (HTA). The Board of HIQA approved the...

Seanad: Order of Business (10 Jul 2018) See 2 other results from this debate

Colm Burke: ...House, and I was here for most of them, I was still able to attend a conference in the Royal College of Physicians of Ireland where Professor Ian Frazer, who developed the human papilloma virus, HPV vaccine, gave a lecture. It is sad that there were protests outside the college and outside the Dáil by people who were alleging that the vaccine has negative effects. The evidence in...

Seanad: An tOrd Gnó - Order of Business (24 May 2022)

Martin Conway: Last September, I tabled a Commencement matter on the human papillomavirus, HPV, vaccine. The Minister of State, Deputy Rabbitte, came in on behalf of the Minister, Deputy Stephen Donnelly, and committed to eliminating the charge for the catch-up vaccination. I was quite disappointed when this was then referred to the national immunisation advisory committee, NIAC, because what this vaccine...

Written Answers — Department of Health: Vaccination Programme (6 Apr 2016)

Leo Varadkar: I am aware of claims of an association between HPV vaccination and a number of conditions experienced by a group of young women. It appears that some girls first suffered symptoms around the time they received the HPV vaccine, and understandably some parents have connected the vaccine to their daughter’s condition. I want to make it quite clear that anyone who is suffering ill...

Written Answers — Department of Health: Vaccination Programme (21 Jun 2017)

Simon Harris: ...the benefits of vaccines outweigh the known side effects. I am very disappointed that the uptake of certain vaccines, which have been the subject of recent campaigns, has dropped. Most notably HPV vaccine uptake rates have fallen from 87% in 2014/15 to 72% in 2015/16. This is a very serious development as a large number of girls are now at risk of developing cervical cancer later in...

Written Answers — Department of Health: Medicinal Products Regulation (10 May 2017)

Simon Harris: As I stated in my previous response, there is no scientific evidence that the HPV vaccine causes any long-term illness. The safety of all medicines, including vaccines, is not a trivial matter and there are robust regulatory and monitoring systems in place at both EU and national level to ensure that the medicines we use are safe and effective. The Health Products Regulatory Authority...

Written Answers — Department of Health: Vaccination Programme Data (26 Mar 2019) See 3 other results from this answer

Simon Harris: ...of Gardasil in 2006 and up to 31/12/2018, the Health Products Regulatory Authority (HPRA) had received 1,187 reports/cases of suspected adverse reactions and events associated with the use of the HPV vaccines (Gardasil, Cervarix and a few reports for which the brand of vaccine is not known).  These reports include information on some 5,616 reactions, as many reports/cases contain...

Written Answers — Department of Health: Clinical Trials (3 Nov 2015)

Kathleen Lynch: ...EMA with input from member state competent authorities, including Ireland's Health Products Regulatory authority (HPRA). With particular regard to the Deputy's query on the human papilloma virus (HPV) cervical cancer vaccine, there are 2 authorised HPV vaccines available in Ireland (Gardasil®and Cervarix®). Gardasil®is the vaccine used by the HSE in the School Immunisation...

Order of Business (13 Nov 2008) See 1 other result from this debate

Caoimhghín Ó Caoláin: The decision not to proceed with the HPV vaccination programme is undoubtedly very serious. However, we learned yesterday that the HSE has confirmed that the diabetic retinopathy screening programme that was scheduled to commence this year will not now proceed because of so-called resource constraints.

Written Answers — Vaccination Programme: Vaccination Programme (25 Nov 2008) See 1 other result from this answer

Kathleen Lynch: Question 128: To ask the Minister for Health and Children when she will introduce the HPV vaccine for cervical cancer for 12 year old girls in a school-based programme; and if she will make a statement on the matter. [42437/08]

Health Bill 2008: Second Stage (Resumed) (11 Dec 2008)

Caoimhghín Ó Caoláin: If there is loads of money, what about the HPV vaccination?

Written Answers — Vaccination Programme: Vaccination Programme (27 Jan 2009) See 1 other result from this answer

James Bannon: Question 377: To ask the Minister for Health and Children her plans to roll back on her decision taken in 2008, with regard to the provision of the HPV vaccine; and if she will make a statement on the matter. [1062/09]

Written Answers — Health Services: Health Services (12 May 2009) See 1 other result from this answer

Mary Harney: The centre referred to by the Deputy that is providing the HPV vaccine is a GP practice where a private arrangement is in place for their own patients. Neither my Department or the HSE have any role in this matter.

Written Answers — Vaccination Programme: Vaccination Programme (9 Feb 2010) See 2 other results from this answer

Deirdre Clune: Question 272: To ask the Minister for Health and Children the persons entitled to receive the HPV vaccine; and if she will make a statement on the matter. [6784/10]

Written Answers — Vaccination Programme: Vaccination Programme (20 Apr 2010) See 2 other results from this answer

Joanna Tuffy: Question 336: To ask the Minister for Health and Children if the HPV vaccine will commence in secondary schools before May 2010; and if she will make a statement on the matter. [15070/10]

Written Answers — Vaccination Programme: Vaccination Programme (27 Apr 2010)

Mary Harney: The public HPV vaccination programme for first year girls in secondary schools will start before the end of this school term. During this calendar year all girls currently in first year will be offered the vaccination.

Written Answers — Tax Code: Tax Code (4 Nov 2010) See 1 other result from this answer

Noel Ahern: Question 119: To ask the Minister for Finance the tax relief available to parents who wish their older schoolgoing daughters to be protected by the HPV vaccine; and if he will make a statement on the matter. [40896/10]

Written Answers — Vaccination Programme: Vaccination Programme (29 Mar 2011)

James Reilly: I have asked the HSE to develop an implementation plan for a catch-up programme for HPV vaccination of girls in secondary school, to commence in the new school year this autumn.